ResearcherLyon 1 UniversitéActive in the last 2 years
Julie Périnel
Matched on ORCID iD 0000-0002-9040-9728; OpenAlex author ID A5071791624. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 55
2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers
Papers 8
- Aborted pancreatoduodenectomy after extensive vascular dissection in patients with pancreatic cancer: a word of caution. First author DOI 10.1007/s00464-024-11073-6↗
- Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study. Co-author DOI 10.1093/bjsopen/zrad125↗
- Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort. Co-author DOI 10.1016/j.ejso.2018.12.012↗
- Palliative therapy in pancreatic cancer-palliative surgery. Co-author DOI 10.21037/tgh.2019.04.03↗
- Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. Co-author DOI 10.1245/s10434-018-6391-z↗
- Correction to: Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. Co-author DOI 10.1245/s10434-018-6442-5↗
- Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two different diseases receive the same treatment?… First author DOI 10.1016/j.ejso.2017.06.011↗
- Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicent… Co-author DOI 10.1016/j.surg.2016.02.019↗
Closest collaborators
The 25 strongest of 55 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mustapha Adham · 8 shared papers, 2016–2024 · strength 0.92
- Paper Aborted pancreatoduodenectomy after extensive vascular dissection in patients with pancreatic cancer: a word of caution. DOI 10.1007/s00464-024-11073-6↗
- Paper Palliative therapy in pancreatic cancer-palliative surgery. DOI 10.21037/tgh.2019.04.03↗
- Paper Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study. DOI 10.1093/bjsopen/zrad125↗
- Mircea Chirica · 1 shared paper, 2024 · strength 0.24
- Quentin Chenevas-Paule · 1 shared paper, 2024 · strength 0.24
- Rüdiger Göß · 1 shared paper, 2024 · strength 0.18
- Alexander Muckenhuber · 1 shared paper, 2024 · strength 0.18
- Ilaria Pergolini · 1 shared paper, 2024 · strength 0.18
- Stephan Schorn · 1 shared paper, 2024 · strength 0.18
- Florian Scheufele · 1 shared paper, 2024 · strength 0.18
- Alexander Novotny · 1 shared paper, 2024 · strength 0.18
- Helmut Friess · 1 shared paper, 2024 · strength 0.18
- Okan Safak · 1 shared paper, 2024 · strength 0.18
- İhsan Ekin Demir · 1 shared paper, 2024 · strength 0.18
- Guralp Onur Ceyhan · 1 shared paper, 2024 · strength 0.18
- Claudio Bassi · 3 shared papers, 2018–2019 · strength 0.18
- Paper Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort. DOI 10.1016/j.ejso.2018.12.012↗
- Paper Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Coh… DOI 10.1245/s10434-018-6391-z↗
- Paper Correction to: Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Re… DOI 10.1245/s10434-018-6442-5↗
- Roberto Salvia · 3 shared papers, 2018–2019 · strength 0.18
- Paper Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort. DOI 10.1016/j.ejso.2018.12.012↗
- Paper Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Coh… DOI 10.1245/s10434-018-6391-z↗
- Paper Correction to: Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Re… DOI 10.1245/s10434-018-6442-5↗
- Alain Sauvanet · 3 shared papers, 2017–2018 · strength 0.16
- Paper Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two differ… DOI 10.1016/j.ejso.2017.06.011↗
- Paper Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Coh… DOI 10.1245/s10434-018-6391-z↗
- Paper Correction to: Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Re… DOI 10.1245/s10434-018-6442-5↗
- Giuseppe Malleo · 2 shared papers, 2016–2019 · strength 0.13
- Paper Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort. DOI 10.1016/j.ejso.2018.12.012↗
- Paper Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic… DOI 10.1016/j.surg.2016.02.019↗
- Laura Maggino · 2 shared papers, 2016–2019 · strength 0.13
- Paper Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort. DOI 10.1016/j.ejso.2018.12.012↗
- Paper Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic… DOI 10.1016/j.surg.2016.02.019↗
- Maximilian Bockhorn · 2 shared papers, 2016–2019 · strength 0.13
- Paper Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort. DOI 10.1016/j.ejso.2018.12.012↗
- Paper Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic… DOI 10.1016/j.surg.2016.02.019↗
- Waldemar H. Uhl · 2 shared papers, 2016–2019 · strength 0.13
- Paper Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort. DOI 10.1016/j.ejso.2018.12.012↗
- Paper Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic… DOI 10.1016/j.surg.2016.02.019↗
- Alessandro Zerbi · 2 shared papers, 2016–2019 · strength 0.13
- Paper Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort. DOI 10.1016/j.ejso.2018.12.012↗
- Paper Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic… DOI 10.1016/j.surg.2016.02.019↗
- Jakob Robert Izbicki · 2 shared papers, 2016–2019 · strength 0.13
- Paper Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort. DOI 10.1016/j.ejso.2018.12.012↗
- Paper Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic… DOI 10.1016/j.surg.2016.02.019↗
- Helmut Frieß · 2 shared papers, 2018 · strength 0.10
- Paper Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Coh… DOI 10.1245/s10434-018-6391-z↗
- Paper Correction to: Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Re… DOI 10.1245/s10434-018-6442-5↗
- Matteo De Pastena · 2 shared papers, 2018 · strength 0.10
- Paper Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Coh… DOI 10.1245/s10434-018-6391-z↗
- Paper Correction to: Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Re… DOI 10.1245/s10434-018-6442-5↗
- Willem Niesen · 2 shared papers, 2018 · strength 0.10
- Paper Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Coh… DOI 10.1245/s10434-018-6391-z↗
- Paper Correction to: Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Re… DOI 10.1245/s10434-018-6442-5↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.